Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SHE:300204)
China flag China · Delayed Price · Currency is CNY
15.21
+0.43 (2.91%)
May 23, 2025, 12:44 PM CST

SHE:300204 Statistics

Total Valuation

SHE:300204 has a market cap or net worth of CNY 7.06 billion. The enterprise value is 6.98 billion.

Market Cap 7.06B
Enterprise Value 6.98B

Important Dates

The last earnings date was Friday, April 25, 2025.

Earnings Date Apr 25, 2025
Ex-Dividend Date n/a

Share Statistics

SHE:300204 has 477.77 million shares outstanding.

Current Share Class 477.77M
Shares Outstanding 477.77M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 6.76%
Owned by Institutions (%) 3.94%
Float 260.56M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 24.10
PB Ratio 7.49
P/TBV Ratio 7.85
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -48.68
EV / Sales 23.82
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -84.48

Financial Position

The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.02.

Current Ratio 1.59
Quick Ratio 0.96
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF -0.24
Interest Coverage -56.45

Financial Efficiency

Return on equity (ROE) is -15.05% and return on invested capital (ROIC) is -2.87%.

Return on Equity (ROE) -15.05%
Return on Assets (ROA) -2.35%
Return on Invested Capital (ROIC) -2.87%
Return on Capital Employed (ROCE) -4.55%
Revenue Per Employee 595,623
Profits Per Employee -291,480
Employee Count 555
Asset Turnover 0.24
Inventory Turnover 2.52

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +118.40% in the last 52 weeks. The beta is 0.55, so SHE:300204's price volatility has been lower than the market average.

Beta (5Y) 0.55
52-Week Price Change +118.40%
50-Day Moving Average 9.03
200-Day Moving Average 7.77
Relative Strength Index (RSI) 80.28
Average Volume (20 Days) 35,601,457

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, SHE:300204 had revenue of CNY 293.05 million and -143.41 million in losses. Loss per share was -0.30.

Revenue 293.05M
Gross Profit 232.48M
Operating Income -46.42M
Pretax Income -34.95M
Net Income -143.41M
EBITDA -26.40M
EBIT -46.42M
Loss Per Share -0.30
Full Income Statement

Balance Sheet

The company has 89.44 million in cash and 20.06 million in debt, giving a net cash position of 69.37 million or 0.15 per share.

Cash & Cash Equivalents 89.44M
Total Debt 20.06M
Net Cash 69.37M
Net Cash Per Share 0.15
Equity (Book Value) 942.70M
Book Value Per Share 2.00
Working Capital 83.76M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -61.92 million and capital expenditures -20.72 million, giving a free cash flow of -82.64 million.

Operating Cash Flow -61.92M
Capital Expenditures -20.72M
Free Cash Flow -82.64M
FCF Per Share -0.17
Full Cash Flow Statement

Margins

Gross margin is 79.33%, with operating and profit margins of -15.84% and -48.94%.

Gross Margin 79.33%
Operating Margin -15.84%
Pretax Margin -11.93%
Profit Margin -48.94%
EBITDA Margin -9.01%
EBIT Margin -15.84%
FCF Margin n/a

Dividends & Yields

SHE:300204 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -2.03%
FCF Yield -1.17%

Stock Splits

The last stock split was on May 5, 2016. It was a forward split with a ratio of 1.3995941.

Last Split Date May 5, 2016
Split Type Forward
Split Ratio 1.3995941

Scores

SHE:300204 has an Altman Z-Score of 9.04.

Altman Z-Score 9.04
Piotroski F-Score n/a